Genetics of hypertrophic and dilated cardiomyopathy

Felix W Friedrich1, Lucie Carrier

  • 1Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Insights

Cardiomyopathies are heart muscle diseases. This review focuses on hypertrophic and dilated cardiomyopathies, exploring their genetic causes, molecular mechanisms, and genotype-phenotype relationships in familial cases.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathies are broadly classified as extrinsic (e.g., hypertension, ischemia) or intrinsic (primary myocardial diseases).
  • Primary cardiomyopathies include hypertrophic, dilated, restrictive, and arrhythmogenic right ventricular forms.
  • Hypertrophic and dilated cardiomyopathies are the most prevalent primary forms, with significant familial prevalence and genetic heterogeneity.

Purpose of the Study:

  • To review current knowledge on causative genes for hypertrophic and dilated cardiomyopathies.
  • To elucidate the molecular mechanisms underlying these primary cardiomyopathies.
  • To explore the genotype-phenotype correlations in familial cases of hypertrophic and dilated cardiomyopathies.

Main Methods:

  • Literature review of causative genes, molecular mechanisms, and genotype-phenotype relations.
  • Analysis of diagnostic methods including clinical expression, echocardiography, electrocardiography, non-invasive imaging, and cardiac catheterization.
  • Synthesis of current research on familial hypertrophic and dilated cardiomyopathies.

Main Results:

  • Identified key causative genes and molecular pathways implicated in hypertrophic and dilated cardiomyopathies.
  • Highlighted the genetic and phenotypic diversity within familial forms.
  • Established links between specific genotypes and clinical manifestations.

Conclusions:

  • Understanding the genetic basis of hypertrophic and dilated cardiomyopathies is crucial for diagnosis and management.
  • Further research into molecular mechanisms and genotype-phenotype correlations will advance personalized medicine approaches.
  • Familial screening and genetic counseling are important for affected families.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...